Skip to content

Clinical trials

Observational Bipolar Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Observational Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20101
20113
20122
20141
20152
20191
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Douglas Mental Health University Institute2
University of British Columbia2
Brain and Cognition Discovery Foundation1
Canadian Network for Observational Drug Effect Studies, CNODES1
Daniel Benjamin1
Dr. Ayal Schaffer1
McMaster University1
Nova Scotia Health Authority1
Queen's University1
St. Joseph's Healthcare Hamilton1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder16
Psychotic Disorders5
Major Depressive Disorder3
Mood Disorders3
Schizophrenia3
Stress Disorders, Post-Traumatic2
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.